Document:

hsto-ex101_6.htm

Exhibit 10.1

CONSULTING AGREEMENT

 

This Agreement is made and entered into as of April 29, 2022 (“Effective Date”) by and between Histogen Inc. (“Company”), having a principal place of business at 10655 Sorrento Valley Road, Suite 200, San Diego, CA 92121   and Latterich Consulting Services LLC (“Consultant”) having a principal place of business at _____________________________ ____________________________ and shall become effective after Consultant is no longer an employee of the Company and the term of the initial Project Assignment commences as set forth in Exhibit A (Project Assignment).

1.Engagement of Services. Company may issue Project Assignments to Consultant in the form attached to this Agreement as Exhibit A.  A Project Assignment will become binding when both parties have signed it and once signed, Consultant will be obligated to provide the services and to deliver the materials and deliverables as specified in each Project Assignment.  The terms of this Agreement will govern all Project Assignments and services undertaken by Consultant for Company.  Consultant represents, warrants and covenants that Consultant will perform the services under this Agreement in a timely, professional and workmanlike manner and that all materials and deliverables provided to Company will comply with (i) the requirements set forth in the Project Assignment, (ii) the documentation and specifications for those materials and deliverables, (iii) any samples or documents provided by Consultant to Company.

2.Compensation; Timing.  Company will pay Consultant the fee set forth in each Project Assignment for the services provided as specified in that Project Assignment.  If provided for in the Project Assignment, Company will reimburse Consultant’s documented, out-of-pocket expenses no later than thirty (30) days after Company’s receipt of Consultant’s invoice, except that reimbursement for expenses may be delayed until that time when Consultant furnishes adequate supporting documentation for the authorized expenses as Company may reasonably request.  Upon termination of this Agreement for any reason, Consultant will be (a) paid fees on the basis stated in the Project Assignment(s) and (b) reimbursed only for expenses that are properly incurred prior to termination of this Agreement and which are either expressly identified in a Project Assignment or approved in advance in writing by the Company. 

3.Independent Contractor Relationship.  Consultant’s relationship with Company is that of an independent contractor, and nothing in this Agreement is intended to, or shall be construed to, create a partnership, agency, joint venture, employment or similar relationship.  Consultant will not be entitled to any of the benefits that Company may make available to its employees.  Consultant is solely responsible for all tax returns and payments required to be filed with, or made to, any federal, state or local tax authority with respect to the performance of services and receipt of fees under this Agreement.  No part of Consultant’s compensation will be subject to withholding by Company for the payment of any social security, federal, state or any other employee payroll taxes.  Company will regularly report amounts paid to Consultant by filing Form 1099‐MISC with the Internal Revenue Service as required by law. In the event that, notwithstanding this Section 3, if Consultant is an individual and is found by a court of competent jurisdiction to be an employee of Company, the Parties acknowledge and agree that works of authorship and other intellectual property that would qualify fully for exemption from assignment under the provisions of Section 2870 of the California Labor Code will not constitute Company Innovations for the purposes of assignment under Section 4.2 (Disclosure and Assignment of Company Innovations) of this Agreement.

4.Disclosure and Assignment of Work Resulting from Project Assignments.

4.1“Innovations” and “Company Innovations” Definitions.  In this Agreement, “Innovations” means all discoveries, designs, 

1

 

developments, improvements, inventions (whether or not protectable under patent laws), works of authorship, information fixed in any tangible medium of expression (whether or not protectable under copyright laws), trade secrets, know-how, ideas (whether or not protectable under trade secret laws), mask works, trademarks, service marks, trade names and trade dress.  “Company Innovations” means Innovations that Consultant, solely or jointly with Company or with others, creates, derives, conceives, develops, makes or reduces to practice under a Project Assignment. 

4.2Disclosure and Assignment of Company Innovations.  Consultant agrees to maintain adequate and current records of all Company Innovations, which records shall be and remain the property of Company.  Consultant agrees to promptly disclose and describe to Company all Company Innovations.  Consultant represents, warrants and covenants that all Company Innovations shall be free and clear of any liens and encumbrances.  Consultant hereby does and will irrevocably assign to Company or Company’s designee all of Consultant’s right, title and interest in and to any and all Company Innovations and all associated records, such assignment to occur with respect to each Company Innovation at the time the Company Innovation is first conceived, made, derived, developed, written or created, and regardless of when the Company Innovation is first conceived, made, derived, developed, written or created.  To the extent any of the rights, title and interest in and to Company Innovations cannot be assigned by Consultant to Company, Consultant hereby grants to Company an exclusive, royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit those non-assignable rights, title and interest, including, but not limited to, the right to make, use, sell, offer for sale, import, have made, and have sold, the Company Innovations.  To the extent any of the rights, title and interest in and to the Company Innovations can neither be assigned nor licensed by Consultant to Company, Consultant hereby irrevocably waives and agrees never to assert the non-assignable and non-licensable rights, title and interest against Company, any of Company’s successors in interest, or any of Company’s customers.  If Consultant is a legal entity as opposed to an individual and if any Company Innovations include any work of authorship that qualifies as a “work made for hire” as defined in subclause (2) under Section 101 of the Copyright Law of the United States (Title 17 of the United States Code, as may be amended from time to time), Company and Consultant agree that Company owns such work of authorship as a work made for hire under such section.

4.3Assistance.  Consultant agrees to perform, during and after the term of this Agreement, all acts that Company deems necessary or desirable to permit and assist Company, at its expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, rights and title throughout the world in the Company Innovations as provided to Company under this Agreement.  If Company is unable for any reason to secure Consultant’s signature to any document required to file, prosecute, register or memorialize the assignment of any rights under any Company Innovations as provided under this Agreement, Consultant hereby irrevocably designates and appoints Company and Company’s duly authorized officers and agents as Consultant’s agents and attorneys-in-fact to act for and on Consultant’s behalf and instead of Consultant to take all lawfully permitted acts to further the filing, prosecution, registration, memorialization of assignment, issuance and enforcement of rights in, to and under the Company Innovations, all with the same legal force and effect as if executed by Consultant.  The foregoing is deemed a power coupled with an interest and is irrevocable.

4.4Consultant Out-of-Scope Innovations.  If Consultant incorporates or permits to be incorporated any Innovations relating in any way, at the time of conception, reduction to practice, creation, derivation, development or making of the Innovation, to Company’s business or actual or demonstrably anticipated research or development but which were conceived, reduced to practice, created, derived, developed or made by Consultant (solely or jointly) either unrelated to Consultant’s work for Company under this 

1

 

Agreement or prior to the Effective Date (collectively, the “Out-of-Scope Innovations”) into any of the Company Innovations, then Consultant hereby grants to Company and Company’s designees a royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit all patent, copyright, moral right, mask work, trade secret and other intellectual property rights relating to the Out-of-Scope Innovations.  Notwithstanding the foregoing, Consultant agrees that Consultant shall not incorporate, or permit to be incorporated, any Innovations conceived, reduced to practice, created, derived, developed or made by others or any Out-of-Scope Innovations into any Company Innovations without Company’s prior written consent.

5.Confidentiality.

5.1Definition of Confidential Information. “Confidential Information” means (a) any technical and non-technical information related to the Company’s business and current, future and proposed products and services of Company, including for example and without limitation, Company Innovations, Company Property (as defined in Section 6 (Ownership and Return of Confidential Information and Company Property)), and Company’s information concerning research, development, design details and specifications, financial information, procurement requirements, engineering and manufacturing information, customer lists, business forecasts, sales information, marketing plans and business plans, Personal Information (as defined in Section 5.3 (Consultant as Service Provider)), pricing and compensation information, in each case whether or not marked as “confidential” or “proprietary” and (b) any information that Company has received from others that may be made known to Consultant and that Company is obligated to treat as confidential or proprietary, whether or not marked as “confidential” or “proprietary”.

5.2Nondisclosure and Nonuse Obligations.  Except as permitted in this Section and Section 12 (Defend Trade Secrets Act), Consultant will not (i) use any Confidential Information or (ii) disseminate or in any way disclose the Confidential Information to any person, firm, business or governmental agency or department.  Consultant may use the Confidential Information solely to perform Project Assignment(s) for the benefit of Company.  Consultant shall treat all Confidential Information with the same degree of care as Consultant accords to Consultant’s own confidential information, but in no case shall Consultant use less than reasonable care.  If Consultant is not an individual, Consultant shall disclose Confidential Information only to those of Consultant’s employees who have a need to know the information as necessary for Consultant to perform this Agreement.  Consultant certifies that each of its employees will have agreed, either as a condition of employment or in order to obtain the Confidential Information, to be bound by terms and conditions at least as protective as those terms and conditions applicable to Consultant under this Agreement.  Consultant shall immediately give notice to Company of any unauthorized use or disclosure of the Confidential Information.  Consultant shall assist Company in remedying any the unauthorized use or disclosure of the Confidential Information.  Consultant agrees not to communicate any information to Company in violation of the proprietary rights of any third party.

 

5.3Exclusions from Nondisclosure and Nonuse Obligations.  Consultant’s obligations under Section 5.2 do not apply to any Confidential Information that Consultant can demonstrate (a) was in the public domain at or subsequent to the time the Confidential Information was communicated to Consultant by Company through no fault of Consultant; (b) was rightfully in Consultant’s possession free of any obligation of confidence at or subsequent to the time the Confidential Information was communicated to Consultant by Company; or (c) was independently developed by employees of Consultant without use of, or reference to, any Confidential Information communicated to Consultant by Company.  A disclosure of any Confidential Information by Consultant (a) in response to a valid order by a court or other governmental body or (b) as otherwise required 

2

 

by law will not be considered to be a breach of this Agreement or a waiver of confidentiality for other purposes; provided, however, that Consultant provides prompt prior written notice thereof to Company to enable Company to seek a protective order or otherwise prevent the disclosure. Nothing in this Agreement will limit Consultant’s ability to provide truthful information to any government agency regarding potentially unlawful conduct.

6.Ownership and Return of Confidential Information and Company Property.  All Confidential Information and any materials and items (including, without limitation, software, equipment, tools, artwork, documents, drawings, papers, diskettes, tapes, models, apparatus, sketches, designs, Personal Information, and lists) that Company furnishes to Consultant by Company, whether delivered to Consultant by Company or made by Consultant in the performance of services under this Agreement and whether or not they contain or disclose Confidential Information (collectively, the “Company Property”), are the sole and exclusive property of Company or Company’s suppliers or customers.  Consultant agrees to keep all Company Property at Consultant’s premises unless otherwise permitted in writing by Company.  Within five (5) days after any request by Company, Consultant shall destroy or deliver to Company, at Company’s option, (a) all Company Property and (b) all materials and items in Consultant’s possession or control that contain or disclose any Confidential Information.  Consultant will provide Company a written certification of Consultant’s compliance with Consultant’s obligations under this Section.

7.Indemnification.  Consultant will indemnify and hold harmless Company from and against any and all third party claims, suits, actions, demands and proceedings against Company and all losses, costs and liabilities related thereto arising out of or related to (i) an allegation that any item, material and other deliverable delivered by Consultant under this Agreement infringes any intellectual property rights or publicity rights of a third party or (ii) any negligence by Consultant or any other act or omission of Consultant, including without limitation any breach of this Agreement by Consultant.

8.Limitation of Liability. Except for liabilities arising under Article 4 (Disclosure and Assignment of Work Resulting from Project Assignments), Article 5 (Confidentiality) and Article 7 (Indemnification), the maximum aggregate liability of either party to the other party arising out of or related to this Agreement will not exceed the fees paid by the Company to the Consultant hereunder.

9.Observance of Company Rules.  At all times while on Company’s premises, Consultant will observe Company’s rules and regulations with respect to conduct, health, safety and protection of persons and property.

10.No Conflict of Interest.  During the term of this Agreement, Consultant will not accept work, enter into a contract or accept an obligation inconsistent or incompatible with Consultant’s obligations, or the scope of services to be rendered for Company, under this Agreement.  Consultant warrants that, to the best of Consultant’s knowledge, there is no other existing contract or duty on Consultant’s part that conflicts with or is inconsistent with this Agreement.  Consultant agrees to indemnify and hold harmless Company from any and all losses and liabilities incurred or suffered by Company by reason of the alleged breach by Consultant of any services agreement between Consultant and any third party.

11.Term and Termination.

11.1Term.  This Agreement is effective as of the Effective Date set forth above and will terminate on December 31, 2022 unless extended by the mutual written consent of the parties or terminated earlier as set forth below.

11.2Termination by Company.  Company may terminate this Agreement without cause at any time, with termination effective fifteen (15) days after Company’s delivery to Consultant of written notice of termination.  Company also may terminate this Agreement (a) immediately upon 

3

 

Consultant’s breach of Section 4 (Disclosure and Assignment of Work Resulting from Project Assignments), 5 (Confidentiality) or (b) immediately for a breach by Consultant if Consultant’s breach of any other provision under this Agreement or obligation under a Project Assignment is not cured within five (5) days after the date of Company’s written notice of breach.  Company may terminate a Project Assignment at any time upon three (3) days’ prior written notice to Consultant and, in that event, Company will pay Consultant for services properly performed prior to the date of termination.

11.3Termination by Consultant.  Except during the term of a Project Assignment, Consultant may terminate this Agreement without cause at any time, with termination effective fifteen (15) days after Consultant’s delivery to Company of written notice of termination.  Consultant also may terminate this Agreement immediately for a material breach by Company if Company’s material breach of any provision of this Agreement is not cured within ten (10) days after the date of Consultant’s written notice of breach.

11.4Effect of Expiration or Termination.  Upon expiration or termination of this Agreement, Company shall pay Consultant for services properly performed under this Agreement as set forth in each then pending Project Assignment.  The definitions contained in this Agreement and the rights and obligations contained in this Section and Sections 4 (Disclosure and Assignment of Work Resulting from Project Assignments), 5 (Confidentiality), 6 (Ownership and Return of Confidential Information and Company Property), 7 (Indemnification), and 13 (General Provisions) will survive any termination or expiration of this Agreement.

12.Defend Trade Secrets Act.  Pursuant to the Defend Trade Secrets Act of 2016, if Consultant is an individual, Consultant acknowledges that he/she shall not have criminal or civil liability under any Federal or State trade secret law for the disclosure of a trade secret that  (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In addition, if Consultant files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Consultant may disclose the trade secret to Consultant’s attorney and may use the trade secret information in the court proceeding, if Consultant (X) files any document containing the trade secret under seal and (Y) does not disclose the trade secret, except pursuant to court order.

13.General Provisions.

13.1Successors and Assigns.  Consultant shall not assign its rights or delegate any performance under this Agreement without the prior written consent of Company.  For the avoidance of doubt, Consultant may not subcontract performance of any services under this Agreement to any other contractor or consultant without Company’s prior written consent.  All assignments of rights by Consultant are prohibited under this paragraph, whether they are voluntary or involuntary, by merger, consolidation, dissolution, operation of law, or any other manner. For purposes of this paragraph, (i) a “change of control” is deemed an assignment of rights; and (ii) “merger” refers to any merger in which Consultant participates, regardless of whether it is the surviving or disappearing entity.  Any purported assignment of rights or delegation of performance in violation of this paragraph is void. This Agreement will be for the benefit of Company’s successors and assigns, and will be binding on Consultant’s permitted assignees.

13.2Injunctive Relief.  Consultant’s obligations under this Agreement are of a unique character that gives them particular value; Consultant’s breach of any of these obligations will cause irreparable and continuing damage to Company for which money damages are insufficient, and Company is entitled to injunctive relief, a decree for specific performance, and all other relief as may be proper 

4

 

(including money damages if appropriate), without the need to post a bond.

13.3Notices. Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows, with notice deemed given as indicated:  (a) by personal delivery, when actually delivered; (b) by overnight courier, upon written verification of receipt; (c) by facsimile transmission, upon acknowledgment of receipt of electronic transmission; (d) by email, effective (A) when the sender receives an automated message from the recipient confirming delivery or (B) one hour after the time sent (as recorded on the device from which the sender sent the email) unless the sender receives an automated message that the email has not been delivered, whichever happens first, but if the delivery or receipt is on a day which is not a business day or is after 5:00 pm (addressee’s time) it is deemed to be received at 9:00 am on the following business day; or (e) by certified or registered mail, return receipt requested, upon verification of receipt.  Notices to each party shall be sent to the address first written above, or other address as a party may provide in writing.

13.4Governing Law; Forum.  The laws of the United States of America and the State of Delaware govern all matters arising out of or relating to this Agreement without giving effect to any conflict of law principles.  Each of the parties irrevocably consents to the exclusive personal jurisdiction of the federal and state courts located in San Diego County, California, as applicable, for any matter arising out of or relating to this Agreement, except that in actions seeking to enforce any order or any judgment of the federal or state courts located in San Diego County, California, personal jurisdiction will be non-exclusive.  Additionally, notwithstanding anything in the foregoing to the contrary, a claim for equitable relief arising out of or related to this Agreement may be brought in any court of competent jurisdiction.  If a proceeding is commenced to resolve any dispute that arises between the parties with respect to the matters covered by this Agreement, the prevailing party in that proceeding is entitled to receive its reasonable attorneys’ fees, expert witness fees and out-of-pocket costs, in addition to any other relief to which that prevailing party may be entitled. 

13.5Severability.  If a court of law holds any provision of this Agreement to be illegal, invalid or unenforceable, (a) that provision shall be deemed amended to achieve an economic effect that is as near as possible to that provided by the original provision and (b) the legality, validity and enforceability of the remaining provisions of this Agreement shall not be affected.

13.6Waiver; Modification.  If Company waives any term, provision or Consultant’s breach of this Agreement, such waiver shall not be effective unless it is in writing and signed by Company.  No waiver by a party of a breach of this Agreement shall constitute a waiver of any other or subsequent breach by Consultant.  This Agreement may be modified only by mutual written agreement of authorized representatives of the parties. 

13.7Entire Agreement.  This Agreement constitutes the final and exclusive agreement between the parties relating to this subject matter and supersedes all agreements, whether prior or contemporaneous, written or oral, concerning such subject matter.

 

 

[Signature Page will follow]

 

5

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

	
 “Company”
	
“Consultant”

	
HISTOGEN INC.
	
LATTERICH CONSULTING SERVICES LLC

 

	
By:   /s/  Susan A. Knudson                          
	
By:  /s/  Martin Latterich, Ph.D.                    

	
Name: Susan A. Knudson

Title:  EVP, CFO & Corporate Secretary
	
Name:  Martin Latterich, Ph.D.

Title:  Principal

 

 

 

 

Exhibit A

PROJECT ASSIGNMENT

effective as of May 6, 2022

 

Description of Work and Compensation – Latterich Consulting Services LLC (Martin Latterich, Ph.D., Consultant)

Scope of Work: As directed by the Company, Consultant will ensure that Martin Latterich, Ph.D., shall provide services to the Company related to support for the Company’s development programs as may be requested by the Company’s chief executive officer and / or president, including, but not limited to:

	
 
	
•
	
Biologic and caspase programs;

	
 
	
•
	
All intellectual property related services; 

	
 
	
•
	
Related transitional support.  

It is anticipated that Consultant shall provide such services at least one (1) day a week onsite through June 30, 2022 and otherwise such services shall be provided remote from the Company’s primary facilities.  

Compensation: Company will pay the Consultant a fee of Twelve Thousand Dollars ($12,000) per month for work performed, which fee shall be pro-rated for any partial month of service. Any reimbursement of expenses to the Consultant must be pre-approved in writing by the Company.

In addition, the Company agrees that the unvested stock options identified in the following table shall continue to vest in accordance with their existing vesting terms through the expiration or termination of the Project Term (as defined below): 

										
	
MARTIN LATTERICH

SUMMARY OF GRANTS AS OF MAY 5, 2022

 

	
Grant Date
	
Expiration Date
	
Name
	
Strike Price
	
Terms
	
Vesting Start Date
	
Vesting End Date
	
Options Granted

	
10/7/2016
	
10/7/2026
	
Martin Latterich
	
$3.70
	
4 years, 1 yr 25% cliff, monthly over 36 mos thereafter.
	
10/6/2016
	
10/6/2020
	
28,684

	
3/12/2018
	
3/12/2028
	
Martin Latterich
	
$3.84
	
4 years, 1 yr 25% cliff, monthly over 36 mos thereafter.
	
4/10/2017
	
4/10/2020
	
14,342

	
1/13/2021
	
1/13/2031
	
Martin Latterich
	
$0.97
	
4 years, 1 yr 25% cliff, monthly over 36 mos thereafter.
	
1/13/2021
	
1/13/2025
	
87,300

	
2/17/2022
	
2/17/2032
	
Martin Latterich
	
$0.24
	
4 years, 1 yr 25% cliff, monthly over 36 mos thereafter.
	
2/17/2022
	
2/17/2026
	
17,300

 

	
 
	
•
	
Consultant agrees to invoice Company on the last day of each month. Invoices should include days worked, brief description of work performed, and payment remittance information for ACH payments. Invoices will be paid 30 days from date of invoice. Invoices should be sent to _____.

Term:  The term of this Consulting Agreement shall commence on May 6, 2022, subject to Dr. Latterich no longer being an employee of the Company, and expire on December 31, 2022; provided, however, each party shall be able to terminate this Project Assignment as provided in Section 11 of the Consulting Agreement (the “Project Term”).  This Project Term may be extended by mutual written agreement of the parties. 

 

 

 

Contact information:

	
 
	
•
	
Company: Susan A. Knudson 

Executive Vice President, Chief Financial Officer & Corporate Secretary

10655 Sorrento Valley Road, Suite 200

San Diego, CA 92121  

E-mail: ____________________

 

	
 
	
•
	
Consultant: Latterich Consulting Services LLC 

___________________________

___________________________

E-mail:  ____________________

 

 

NOTE:  This Project Assignment is governed by the terms of a Consulting Agreement in effect between Company and Consultant, effective as of May 6, 2022.  Any term in this Project Assignment that is inconsistent with that agreement is invalid.

 

[Signature page to follow]

 

 

 

 

IN WITNESS WHEREOF, the parties are signing this Project Assignment as of the later date below.

	
 “Company”
	
“Consultant”

	
HISTOGEN INC.

 

 
	
LATTERICH CONSULTING SERVICES LLC

 

	
By:   /s/  Susan A. Knudson                              
	
By:     /s/  Martin Latterich, Ph.D.                          

	
Name:  Susan A. Knudson
	
Name:  Martin Latterich, Ph.D. 

	
Title:  EVP, CFO & Corporate Secretary
	
Title: Principal

	
Date:  April 29, 2022
	
Date:  April 29, 2022Document

L3Harris Proprietary Information

Exhibit 10.1

CONDITIONAL WAIVER, SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS
JESUS (JAY) MALAVE

This CONDITIONAL WAIVER, SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS (this “Agreement”) is between L3Harris Technologies, Inc. (“L3Harris”) and JESUS (JAY) MALAVE   (“you,” “your” and similar words).  The intent of this Agreement is to mutually and finally resolve all matters relating to your employment with and separation from L3Harris.    

1.    Separation Date and Treatment.  Your employment with L3Harris will end at close of business on January 21, 2022 (your “Separation Date”).  You will be paid any accrued but unpaid base salary on the next regularly scheduled payroll date after the Separation Date.  For purposes of any post-separation benefits applicable to you (other than equity awards), your separation from employment will be treated and designated as a voluntary resignation.  Benefit accruals and contributions under the Retirement Savings Plan and Excess Retirement Savings Plan, including matching contributions, will end as of your Separation Date.  

2.    Conditional Waiver of Non-Competition Provisions.  You are currently subject to covenants prohibiting you from, directly or indirectly, as an employee or officer or investor or in other capacities, participating in any activities with, or providing services to, a competitive business for a period of not less than the twelve (12) month period following your employment termination date.  Such covenants are referred to in this Agreement as the “Existing Non-Compete Agreements” (which are listed on Attachment A to this Agreement).  You acknowledge and agree L3Harris has the right to enforce the Existing Non-Compete Agreements and to enjoin you from participating as an employee, officer or otherwise with a competitive business.  You have requested that L3Harris waive and not enforce the Existing Non-Compete Agreements and provide consent for you to become the Chief Financial Officer of Lockheed Martin Corporation.  Subject to the conditions set forth below in this Section 2, L3Harris agrees to waive the Existing Non-Compete Agreements and to consent to you becoming a full-time employee of Lockheed Martin Corporation (but no other competitive business).  This waiver and consent is subject to your compliance with your obligations and agreements contained in this Agreement, including without limitation the condition that you at all times fully comply with and do not breach the following sections of this Agreement:

        (a)    Section 18 “Confidentiality”;
        (b)    Section 19 “Employee Non-Solicitation/Non-Engagement”;
        (c)    Section 20 “Non-Disparagement”;
        (d)    Section 21 “Non-Competition”; and
        (e)    Section 22 “Recusal and Other Protective Provisions.”

The waiver and consent is also conditional on your timely executing and delivering this Agreement to L3Harris and not revoking the Release of All Claims set forth herein.  The waiver and consent provided in this Section is referred to in this Agreement as the “Conditional Waiver.”

You acknowledge and agree that if you do not fully satisfy and comply with the Conditional Waiver, the Conditional Waiver will be null and void and terminated as if it had never been granted.  In such instance, you agree that L3Harris will be entitled to fully enforce the Existing Non-Compete Agreements (notwithstanding that you may have commenced employment at a competitive business) in addition to enforcement of this Agreement, including but not limited to, Sections 18, 19, 20, 21, and 22.  Furthermore, in accordance with Section 7 of this Agreement, you agree that if you do not fully satisfy and comply with the Conditional Waiver and the Sections referenced therein, you will forfeit 3,092 vested Restricted Stock Units and/or the value associated with such units.

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 1 of 12

L3Harris Proprietary Information

Exhibit 10.1

3.    Benefits.  Effective as of the close of business on the Separation Date, you will cease to be eligible for the employee benefit plans, programs and arrangements maintained by L3Harris in accordance with the applicable terms thereof. For the purpose of the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), 29 U.S.C. § 1161 et seq., your Separation Date shall serve as the “qualifying event” for the purpose of any rights you may have under COBRA.  If you participate in the Medical, Dental, or Vision or a Health Care Flexible Spending Account, you will be offered the opportunity to elect continued coverage for yourself and your qualifying dependents in accordance with COBRA.  L3Harris will not pay any premiums due under the Medical, Dental or Vision Plans.  You may continue coverage for the COBRA period at the full monthly cost plus a 2% administrative fee.  If you do not elect COBRA within the time period required under COBRA, your healthcare benefits and Health Care Flexible Spending Account participation will end on your Separation Date.

4.    Annual Incentive Plan.  You acknowledge and agree that in consideration of this Agreement and other good and valuable consideration, including without limitation the Conditional Waiver, the receipt and sufficiency of which is hereby acknowledged and notwithstanding any terms of the L3Harris Annual Incentive Plan (“AIP”) to the contrary, L3Harris may in its sole and absolute discretion determine that you are not entitled to any payment under the AIP in respect of L3Harris’ completed fiscal year 2021, and you hereby waive any entitlement to an AIP payout for L3Harris’ completed fiscal year 2021.
  
5.    Stock Options.  The stock options you hold as of the Separation Date (including Performance Stock Options) will be governed by the terms of the applicable L3Harris Equity Incentive Plan(s) and terms and conditions thereunder in effect at the time of the grant (as amended, if applicable).  You agree that this Section supersedes any contrary provision in your award agreements and that  all of your stock options (vested or unvested, exercised or unexercised) will, as of the Separation Date, immediately expire, and be cancelled, terminated and forfeited in their entirety and shall not be exercisable to any extent.  For purposes of clarity, you agree that you have waived the right to exercise any vested stock options after the Separation Date.

6.    Performance Unit Awards.  Your outstanding performance unit awards (including “Momentum” awards) which you hold as of the Separation Date will be governed by the terms of the L3Harris Equity Incentive Plan(s) and terms and conditions thereunder in effect at the time of grant (as amended, if applicable).  You agree that this Section supersedes any contrary provision in your award agreements and that all of your performance unit awards (vested or unvested, exercised or unexercised) will, as of the Separation Date, immediately expire, and be cancelled, terminated and forfeited in their entirety.  

7.    Restricted Unit Awards.  (a)  Your outstanding unvested restricted unit awards which you hold as of the Separation Date will be governed by the terms of the applicable L3Harris Equity Incentive Plan(s) and terms and conditions thereunder in effect at the time of the grant (as amended, if applicable).  You agree that this Section supersedes any contrary provision in your award agreements and that  all of your unvested restricted units will, as of the Separation Date, immediately expire, and be cancelled, terminated and forfeited in their entirety.

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 2 of 12

L3Harris Proprietary Information

Exhibit 10.1

(b)    Prior to your Separation Date, 3,092 Restricted Stock Units granted on August 1, 2019 vested.  You agree that if you  breach any of the provisions of Sections 18, 19, 20, 21, and 22 of this Agreement, in addition to any and all other remedies available to L3Harris (including under Section 23), L3Harris shall have the right to reclaim and receive from you: (i) all shares of L3Harris stock and cash, as applicable, issued or paid to you in respect of restricted units that have vested prior to the Separation Date; or (ii) to the extent that you have transferred such shares, the fair market value thereof (as of the date such shares were transferred by you) in cash.  Any such return of shares or payment of cash by you shall be made within five (5) business days following receipt of written demand therefore.

8.    No Outplacement Assistance.  You will not be eligible for the outplacement program and you will not receive cash in lieu thereof.

9.    No Further Benefits.  Unless otherwise expressly provided in this Agreement or pursuant to applicable L3Harris employee compensation or benefit arrangements, you will not be entitled to any pay, wages, paid time off, compensation, severance, insurance, or employment benefits from L3Harris after your Separation Date, and you expressly waive and disclaim such benefits or entitlement.  Unless otherwise provided in this Agreement, any post-employment benefits will be governed by the terms and conditions of the applicable plan or program, which may be amended.  

10.    Additional Representations and Warranties.  You acknowledge that you have read and understand L3Harris’ Code of Conduct and that you do not have any information or knowledge as to non-compliance with, or violation of, the policies and standards set forth therein.  You further represent and agree that: (a) you have not instituted, prosecuted, filed, or processed any litigation or other claims or charges against L3Harris that have not previously been communicated to L3Harris in writing; (b) you are not aware of any facts that would give rise to a personal or class action claim against L3Harris under the Family and Medical Leave Act, the Fair Labor Standards Act, any claim for sexual assault, sexual harassment, or any other federal or state statute; (c) you are not aware of any work-related injuries for which you do not already have a pending claim; and (d) you will not sue L3Harris, or join in any lawsuit, or bring or join in any other claim, charge, or proceeding against L3Harris, or any other Releasee (as defined below) concerning any of the claims released by this Agreement.  Notwithstanding the foregoing, to the extent, if any, you have a non-waivable right to file or participate in a claim or charge against L3Harris, this Agreement shall not be intended to waive such a right.  

11.    Indemnification Agreement; Resignation from Office.  (a)  The Indemnification Agreement between you and L3Harris (the “Indemnification Agreement”) will remain in full force or effect for claims, proceedings, liability, or loss you incur arising from that portion of any actual or alleged conduct or wrongful acts in your capacity as an employee and officer of L3Harris that occurred prior to your Separation Date.  In no event shall this Agreement confer any indemnification or advancement rights or protection for claims, proceedings, liability, or loss you incur arising from that portion of any actual or alleged conduct or wrongful acts that occur after your Separation Date.  This Agreement does not waive any rights you may have to indemnification under L3Harris Restated Certificate of Incorporation or By-Laws or to any third-party insurance, including but not limited to any directors and officer’s liability insurance policy(ies) issued to L3Harris. 
 
(b)    You agree that no later than the Separation Date you will resign from any offices, directorships, trusteeships, committee memberships or other positions you hold with L3Harris or 

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 3 of 12

L3Harris Proprietary Information

Exhibit 10.1

any of its affiliates.  You agree to execute any documents provided by L3Harris to effectuate your resignation from such offices, directorships, trusteeships, committee memberships or other positions.

12.    Releasees.  For purposes of this Agreement, “Releasees” include L3Harris and its subsidiaries and affiliated companies and their officers, directors, shareholders, employees, agents, representatives, plans, trusts, administrators, fiduciaries, insurance companies, successors, and assigns.  

13.    Release of All Claims.  You, on behalf of yourself and your personal and legal representatives, heirs, executors, successors and assigns, hereby acknowledge full and complete satisfaction of, and fully and forever waive, release, and discharge Releasees from, any and all claims, causes of action, demands, liabilities, damages, obligations, and debts (collectively referenced as “Claims”), of every kind and nature, whether known or unknown, suspected or unsuspected, that you hold as of the date you sign this Agreement, or at any time previously held, against any Releasee, arising out of any matter whatsoever (except for breach of this Agreement).  This release specifically includes, but is not limited to, any and all Claims:

a.    Arising out of or in any way related to your employment with or separation from L3Harris, or any contract or agreement between you and L3Harris;

b.    Arising under or based on the Equal Pay Act of 1963 (EPA); Title VII of the Civil Rights Act of 1964 (Title VII); Section 1981 of the Civil Rights Act of 1866 (42 U.S.C. §1981); the Civil Rights Act of 1991 (42 U.S.C. §1981a); the Americans with Disabilities Act of 1990 (ADA); the Family and Medical Leave Act of 1993 (FMLA); the Genetic Information Nondiscrimination Act of 2008 (GINA); the National Labor Relations Act (NLRA); the Worker Adjustment and Retraining Notification Act of 1988 (WARN); the Uniform Services Employment and Reemployment Rights Act (USERRA); the Rehabilitation Act of 1973; the Occupational Safety and Health Act (OSHA); the Employee Retirement Income Security Act of 1974 (ERISA) (except claims for vested benefits, if any, to which you are legally entitled); the False Claims Act; Title VIII of the Corporate and Criminal Fraud and Accountability Act (18 U.S.C. §1514A) (Sarbanes-Oxley Act); the federal Whistleblower Protection Act and any state whistleblower protection statute(s); the Florida Civil Rights Act or any other fair employment practice statute(s) of any state, in each case as amended from time to time;

c.    Arising under or based on any other federal, state, county or local law, statute, ordinance, decision, order, policy or regulation prohibiting employment discrimination; providing for the payment of wages or benefits (including overtime and workers’ compensation); or otherwise creating rights or claims for employees, including, but not limited to, any and all claims alleging breach of public policy; the implied obligation of good faith and fair dealing; or any express, implied, oral or written contract, handbook, manual, policy statement or employment practice; or alleging misrepresentation; defamation; libel; slander; interference with contractual relations; intentional or negligent infliction of emotional distress; invasion of privacy; assault; battery; retaliation; fraud; negligence; harassment; retaliation; or wrongful discharge; and

d.    Arising under or based on the Age Discrimination in Employment Act of 1967 (“ADEA”), as amended by the Older Workers Benefit Protection Act (“OWBPA”), and alleging a violation thereof by any Releasee, at any time on or prior to the date this Agreement is executed.

        Notwithstanding the foregoing, the release granted under Section 13 specifically excludes:

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 4 of 12

L3Harris Proprietary Information

Exhibit 10.1

(a)    any violation of any federal, state or local statutory and/or public policy right or entitlement that, by applicable law, may not be waived;
(b)    any right to base salary accrued prior to the Separation Date; and
(c)    any Claim that is based on an act or omission that occurs after the revocation period in Section 25.
14.    Filing an Action Despite Release.  You agree that you will not file a civil action, lawsuit or administrative proceeding against any Releasee with respect to any of the Claims released herein (this does not include claims which, by law, cannot be waived).  This provision prohibits you from recovering monetary or other relief in any legal proceeding brought by you or on your behalf, but does not apply to or limit your right to initiate or participate in an EEOC or other administrative proceeding in which you do not seek personal relief.  This provision also does not preclude you from bringing suit to challenge the validity or enforceability of this Agreement under the ADEA, as amended by the OWBPA.

This Agreement does not limit your ability: (a) to report possible violations of law or regulation to, or file a charge or complaint with, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the National Labor Relations Board, or the Occupational Safety and Health Administration, or any other federal, state or local governmental agency or commission.  This Agreement does not limit your ability under applicable U.S. federal law to: (a) disclose trade secrets in confidence to an attorney or to federal, state and local government officials for the sole purpose of reporting or investigating a suspected violation of law or (b) disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if such filing is made under seal and protected from public disclosure.

15.    Return of Property. You agree that, no later than your Separation Date, you will return to L3Harris all company information and property, in whatever form, including but not limited to laptop, phone, tablets, documents, records, reports, notebooks, drawings, photographs, technical data, credit cards, keys, equipment, computer software, supplies, or other information or property containing confidential or proprietary information of L3Harris or its subsidiaries and affiliates, and you agree that you will not retain copies of same.  You further agree and certify that, no later than your Separation Date, you will permanently delete from your personal computers, tablets or storage devices any and all confidential or proprietary documents and/or information relating to L3Harris and its subsidiaries and affiliates.  

16.    Trading Restrictions; Officer Questionnaire.  (a) You agree and acknowledge that following your Separation Date you shall continue to be subject to the L3Harris securities insider trading policies.  You also acknowledge that trading on the basis of material non-public information, or providing such information to others that may trade, is a violation of the federal securities laws.  You also agree not to trade in any L3Harris securities until after the expiration of ninety (90) days after your Separation Date.

(b)    Upon reasonable request by L3Harris, you shall complete an officer questionnaire in the form provided to L3Harris senior executives, the responses to which may be used to enable L3Harris to comply with the disclosure obligations to the SEC.

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 5 of 12

L3Harris Proprietary Information

Exhibit 10.1

17.    Legal Proceedings and Cooperation.  You agree that you will, to the extent reasonably requested, cooperate with and serve in any capacity reasonably requested by L3Harris in any pending or future investigation (including internal investigation), litigation or proceedings in which L3Harris is or may be a party, and regarding which you, by virtue of your employment with L3Harris, may have knowledge or information which L3Harris deems relevant to said litigation, investigation or proceedings including, but not limited to, acting as L3Harris’ representative or on behalf of L3Harris in any said investigation, litigation, or proceedings.  You further agree that you will, without the necessity for subpoena, provide in any jurisdiction in which L3Harris requests, truthful testimony relevant to said investigation, litigation or proceedings.  In connection with the foregoing, L3Harris will attempt to accommodate your schedule, provide you with reasonable advance notice of the times at which your services are needed and reimburse you for reasonable out-of-pocket expenses.  This provision shall survive termination of this Agreement.

18.    Confidentiality.  In addition to your agreement to return all company information and property to L3Harris, you acknowledge that, while employed by L3Harris, you had access to, acquired and/or assisted in the development of confidential or proprietary information, inventions, and trade secrets relating to the present and anticipated business and operations of L3Harris or its subsidiaries and affiliates, whether or not marked or otherwise designated as confidential, whether in document, electronic or other form and includes, but is not limited to: financial projections, financial forecasts, performance results; research projects; manufacturing or operating processes; sales and marketing methods; business opportunities; marketing plans; sales forecasts and product plans; distributor and customer pricing information; personnel data regarding employees of L3Harris or its subsidiaries and affiliates, including salaries; and other information of a similar confidential nature not available to the public.  You agree to keep confidential and not to disclose or use such confidential and proprietary information, inventions and trade secrets without the prior written consent of a senior executive of L3Harris or until such time as the information, inventions and trade secrets become public knowledge.  You further agree not to use or disclose such confidential or proprietary information, inventions and trade secrets to solicit business directly or indirectly on behalf of any subsequent employer from any present or prospective customer(s) of L3Harris or its subsidiaries or affiliates.  You understand that these obligations continue after your Separation Date.  The provisions of this Section 18 are separate from and in addition to the confidentiality restrictions contained in the equity awards granted to you by L3Harris and accepted by you or in any other confidentiality agreement entered into between you and L3Harris or any subsidiary or affiliate thereof.  Any breach of the above-described additional confidentiality provisions will also constitute a violation and breach of this Agreement.

    The Parties agree that this Agreement is not confidential nor proprietary information of L3Harris and you are permitted to disclose its terms to third parties, including but not limited to your spouse, professional advisors and Lockheed Martin Corporation.  L3Harris agrees that your disclosure of this Agreement shall not be a breach of this Agreement, the confidentiality obligations contained in the equity awards granted to you by L3Harris or any other confidentiality agreement entered into between you and L3Harris or any subsidiary or affiliate thereof.

19.    Employee Non-Solicitation/Non-Engagement.  In consideration of the benefits and consideration to be made to you under this Agreement, including but not limited to the Conditional Waiver, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, commencing on the date hereof and continuing through January 21, 2024, you agree that you will not, directly or indirectly, individually or on behalf of any other employer or any other business, person or entity: (i) recruit, induce, Solicit, attempt to recruit, attempt to induce, or attempt to Solicit any Restricted Employee to terminate, abandon or otherwise leave or discontinue 

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 6 of 12

L3Harris Proprietary Information

Exhibit 10.1

employment with L3Harris or any of its subsidiaries for the purpose of joining or affiliating with Lockheed Martin Corporation or any other Competitive Business; or (ii) hire or cause or assist any Restricted Employee to become employed by or provide services to Lockheed Martin Corporation or any other Competitive Business, person or entity whether as an employee, consultant, contactor or otherwise.  You also agree that this restriction is reasonable and necessary for the protection of L3Harris’ legitimate business interests, that it does not infringe on your ability to earn a living, and that a violation of this restriction will cause irreparable harm to L3Harris.  The provisions of this Section 19 are separate from and in addition to any other non-solicit agreement between you and L3Harris or its subsidiaries or affiliates, including but not limited to the terms and conditions of equity awards granted to you by L3Harris and accepted by you.  Any breach of the above-described additional non-solicitation provisions will also constitute a violation and breach of this Agreement.  For purposes of this Agreement “Solicit” or “Soliciting” means any direct or indirect communication of any kind, regardless of who initiates it, that in any way invites, advises, encourages, engages or requests any person to take or refrain from taking any actions.  For purposes of this Agreement, “Restricted Employee” means any person who, as of the Separation Date, is a Corporate Officer of L3Harris or who holds a job classification  level at L3Harris of XL3, XL2, XL1, or XL0 or any person with whom you dealt in the course of performing your job duties during the twelve (12) months prior to the Separation Date.

20.    Non-Disparagement.  (a) In consideration of the benefits to be made to you under this Agreement, including but not limited to the Conditional Waiver, and for other good and valuable consideration, the receipt and sufficiency of which you hereby acknowledge, you agree that you will not, directly or indirectly, criticize, disparage, defame, or otherwise attempt to impugn the character, integrity or reputation of Releasees or the products or services of L3Harris and its subsidiaries or affiliates (verbally, in writing or otherwise), nor will you unlawfully interfere with any of the business relationships of L3Harris and its subsidiaries or affiliates.  

(b)    L3Harris agrees to instruct its Corporate Officers not to criticize, disparage, defame, or otherwise attempt to impugn your character, integrity or reputation to Lockheed Martin Corporation.  

(c)    The provisions of this Section 20 are separate from and in addition to any other non-disparagement agreement between you and L3Harris or its subsidiaries or affiliates, including but not limited to, the non-disparagement restrictions contained in the equity awards granted to you by L3Harris and accepted by you.  Any breach of the above-described additional non-disparagement provisions will also constitute a violation and breach of this Agreement.  Nothing in this Section 20 is intended or should be construed to prevent you or L3Harris or its designated representatives from providing truthful testimony or information to any person or entity as required by law or fiduciary duties.    

21.    Non-Competition.  (a)  In consideration of the benefits and consideration to be made to you under this Agreement, including but not limited to the Conditional Waiver, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, you agree that from your Separation Date through January 21, 2023, you shall not, directly or indirectly, as an employee, independent contractor, consultant, officer, director, principal, lender or investor engage or otherwise participate in any activities with, or provide services to, a Competitive Business, without the prior written consent of the Vice President, Chief Human Resources or other designated executive officer of L3Harris (which consent shall be at such officer’s discretion to give or withhold).  Nothing in this section shall preclude you from owning up to 1% of the equity in any publicly traded company.  For purposes of this Agreement, “Competitive Business” means any 

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 7 of 12

L3Harris Proprietary Information

Exhibit 10.1

business, person or entity that is engaged, or planning or contemplating to engage within a period of twelve (12) months, in any business activity that is competitive with the business and business activities engaged in by a business unit of L3Harris at the Separation Date.  The provisions of this Section 21 are separate from and in addition to any other non-competition agreement between you and L3Harris or its subsidiaries or affiliates, including but not limited to the Existing Non-Compete Agreements.  Any breach of the Existing No-Compete Agreements will also constitute a violation and breach of this Agreement.  

(b)    Provided you are in compliance with the Conditional Waiver and all other terms of this Agreement, Lockheed Martin Corporation will not be considered a Competitive Business for purposes of this Section 21.

22.    Recusal and Other Protective Provisions.    You agree that from your Separation Date through July 21, 2023 you will recuse yourself from any discussions of or participation in : (1) bids and proposals or awards or other contracts or opportunities in which Lockheed Martin Corporation is in competition with L3Harris or its subsidiaries, and (2) any business opportunity in which L3Harris is a  subcontractor to or a “teammate” or contracting party with Lockheed Martin Corporation, or vice versa. Notwithstanding the expiration of the recusal obligations set forth in this Section 22, you acknowledge and agree that you will remain subject to the confidentiality obligations you have to L3Harris following the expiration of such recusal period, including under Section 18 of this Agreement.

23.    Breach of Agreement; Clawback.  If you file or permit to be filed any civil action, lawsuit, or administrative proceeding against any Releasee seeking personal legal or equitable relief in connection with any matter relating to your employment with or separation from L3Harris, breach the restrictive covenants applicable to you under this Agreement or otherwise breach a provision of this Agreement, in addition to any other rights, remedies, or defenses L3Harris or the other Releasees may have, L3Harris may: (1) immediately terminate this Agreement, if still in effect, without further obligation or liability to you of any kind; (2) recover from you the aggregate dollar value of all pay, insurance, and other benefits provided to you following the Separation Date; (3) recover and reclaim from you shares of L3Harris stock or cash, as the case may be, as set forth in Section 7(b); and (4) recover from you all damages, costs and expenses, including reasonable attorneys’ fees and costs, incurred by L3Harris or the other Releasee(s) in defending such civil action, lawsuit or administrative proceeding or in connection with such breach, including such reasonable attorneys’ fees and costs incurred in recovering such amounts.  You further agree that any breach or threatened breach by you, intentional or otherwise, of the non-solicitation, non-competition or other provisions of this Agreement, including Sections 18, 19, 20, 21, and 22 will entitle L3Harris, in addition to other available remedies, to a temporary and permanent injunction or any other appropriate degree of specific performance in order to enjoin such breach or threatened breach. 

24.    No Admission of Liability.  By entering into this Agreement, L3Harris does not admit to, and expressly denies, any liability or wrongdoing.  In addition, you acknowledge and agree that this Agreement may not be used as evidence to claim or prove any alleged wrongdoing by L3Harris, other than failure to comply with the terms of this Agreement.

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 8 of 12

L3Harris Proprietary Information

Exhibit 10.1

25.    Acknowledgement of ADEA Rights and Informed Consent.  You acknowledge as follows:

a.    You are advised to consult with an attorney or other representative of your choice prior to signing this Agreement;

b.    By executing this Agreement, you waive all rights or claims, if any, that you have or may have against any Releasee under the ADEA, as amended by the OWBPA, and under any state or local laws prohibiting age discrimination;

c.    You are waiving rights and claims that you may have under the ADEA in exchange for consideration that is additional to anything of value to which you are already entitled, including but not limited to, the Conditional Waiver;

d.    You are not waiving rights and claims that you may have under the ADEA that may arise after the date this Agreement is signed;

e.    You fully understand this Agreement and are signing it voluntarily and of your own free will;

f.    You received this Agreement on or prior to your Separation Date, and you have up to 21 calendar days from that date to consider whether to sign it, and such 21-day period will not re-start with changes to this Agreement whether material or immaterial; 

g.    If you wish to sign this Agreement prior to the expiration of the 21-day period explained above, you may do so; 

h.    You have seven (7) calendar days following the date you sign this Agreement to revoke your release of claims under the ADEA, and your release of such claims will not become effective until the revocation period has expired without your revoking it (at which time it will become fully enforceable and irrevocable); and

i.    To revoke your release of claims under the ADEA, you must deliver to L3Harris (via both U.S. mail and electronically), within the 7-day revocation period, a signed written statement that you revoke your release of claims under the ADEA.  The revocation must be postmarked within the period stated above and addressed to:

James P. Girard
Vice President, Chief Human Resources Officer 
L3Harris Technologies, Inc.
1025 W NASA Blvd
Melbourne, Florida 32919

If you revoke your release of claims under the ADEA, you understand that you will not be entitled to receive the benefits and consideration, including the Conditional Waiver, described herein.

26.    Entire Understanding.  This Agreement constitutes the entire agreement between you and L3Harris with respect to the subjects addressed herein.  However, except as specifically set forth in this Agreement, this Agreement is not intended to supersede the provisions of (1) the terms and conditions of equity grants set forth on Attachment A to this Agreement, or (2) any other 

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 9 of 12

L3Harris Proprietary Information

Exhibit 10.1

obligations you may have regarding confidentiality, non-disclosure, intellectual property, ownership of inventions, non-competition and/or non-solicitation pursuant to any agreement with L3Harris or its subsidiaries or affiliates.  

27.    Withholding.  Notwithstanding any other provision of this Agreement, L3Harris may withhold from amounts payable under this Agreement all amounts that are required or authorized to be withheld, including, but not limited to, federal, state, local and foreign taxes to be withheld by applicable laws or regulations.

28.    Successors and Assigns.  This Agreement will be binding in all respects upon, and will inure to the benefit of, the parties’ representatives, heirs, executors, successors, and assigns.

29.    Governing Law.  The parties agree that L3Harris is headquartered in Melbourne, Florida.  The validity and interpretation of this Agreement will be governed exclusively by Florida law without giving effect to principles of conflicts of law.  The parties stipulate that jurisdiction and venue will lie exclusively in Brevard County, Florida or the United States District Court for the Middle District of Florida for any action involving the validity, interpretation and enforcement of this Agreement, for any claim for breach of this Agreement, and for damages or any other relief sought under this Agreement.

30.    Severability and Intent for Court to Enforce Covenants to Maximum Extent.  In the event that any provision of this Agreement is found to be partially or wholly invalid, illegal or unenforceable, the parties agree that such provision shall be modified or restricted as necessary to render it valid, legal and enforceable.  It is expressly understood and agreed that such modification or restriction may be accomplished by mutual accord between the parties or, alternatively, by disposition of a court.  The parties further agree that if such provision cannot under any circumstances be so modified or restricted, it shall be excised from this Agreement without affecting the validity, legality or enforceability of any of the remaining provisions.  You acknowledge and agree that (i) the scope and duration of the restrictions in Sections 18, 19, 20, 21, and 22 are fair and reasonable; (ii) if any provisions of Sections 18, 19, 20, 21, or 22 or any part thereof are held to be unenforceable, the court making such determination shall have the power to revise or modify such provision to make it enforceable to the maximum extent permitted by applicable law and, in its revised or modified form, such provision shall then be enforceable, and if the provision is not capable of being modified or revised so that it is enforceable, it shall be excised from this Agreement without affecting the enforceability of the remaining provisions.
 
31.    Recovery of Previous Awards for Restatements, Etc.  You agree that you will remain subject to Section 15 of the Annual Incentive Plan and Section 13.10 of the 2015 Equity Incentive Plan if any of the L3Harris’ financial restatements are restated as a result of errors, omissions or fraud and L3Harris seeks to recover all or a portion of prior payments or awards made to you under such plans.

32.    Preparation of Agreement.  This Agreement will be interpreted in accordance with the plain meaning of its terms and not strictly for or against any of the parties hereto.  Regardless of which party initially drafted this Agreement, it will not be construed against any one party, and will be construed and enforced as a mutually-prepared document.

33.    Headings.  Section headings are for convenience only and shall not be used to interpret or construe this Agreement.

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 10 of 12

L3Harris Proprietary Information

Exhibit 10.1

34.    Waiver of Jury Trial.  The Parties expressly waive their right to a jury to decide any controversy or claim concerning or arising out of this Agreement.  Any controversy or claim concerning or arising out of this Agreement shall be adjudicated by a judge sitting without a jury.  THIS CONSTITUTES A WAIVER OF JURY RIGHTS.

35.    Counterparts.  This Agreement may be executed in counterparts or by copies transmitted electronically, all of which have the same force and effect as the original.

PLEASE READ AND CAREFULLY CONSIDER THIS AGREEMENT BEFORE SIGNING IT.  THIS AGREEMENT CONTAINS A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS, INCLUDING BUT NOT LIMITED TO THOSE MADE UNDER FEDERAL, STATE, AND/OR LOCAL LAWS PROHIBITING DISCRIMINATION IN EMPLOYMENT, TO THE EXTENT PERMITTED BY LAW. 

YOU AFFIRM AND ACKNOWLEDGE THAT, EXCEPT AS OTHERWISE PROVIDED HEREIN, L3HARRIS HAS PAID YOU ANY AND ALL WAGES, BONUSES, COMMISSIONS, INCENTIVES, SEVERANCE PAY, VACATION PAY AND/OR OTHER PAY OWED TO YOU AS A RESULT OF YOUR EMPLOYMENT BY L3HARRIS, AND YOU AGREE THAT NO SUCH FURTHER PAYMENTS OR AMOUNTS ARE OR WILL BE OWED.

YOU ACKNOWLEDGE THAT THIS AGREEMENT CONTAINS A WAIVER OF JURY RIGHTS.

Agreed to:

Employee:    L3Harris Technologies, Inc.

/s/ Jesus Malave            By: /s/ James P. Girard         
Signature    Name:    James P. Girard
        Title:    Vice President,
            Chief Human Resources Officer

Jesus Malave            Date:    January 21, 2022
Print Name        

    
Date:     January 21, 2022

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 11 of 12

L3Harris Proprietary Information

Exhibit 10.1

Attachment A

EQUITY AWARDS AND EXISTING NON-COMPETE AGREEMENTS

									
	
Grant Date / Type*	
# Granted	Vested Prior to 
January 21, 2022
	8-1-19    Stock Options	34,707	0
	8-1-19    Performance Share Units	3,222	0
	8-1-19    Restricted Units	4,638	3,092
	2-28-20    Stock Options	15,222	5,074    **
	2-28-20    Performance Share Units	5,311	0
	2-28-20    Restricted Share Units	2,656	0
	2-26-21    Stock Options	14,232	0
	2-26-21    Performance Share Units	6,597	0
	2-26-21    Restricted Share Units	3,299	0
	*    All listed equity grants include non-compete provisions which were accepted.
**  Such stock options were terminated, cancelled and forfeited on the Separation Date.
For avoidance of doubt, any and all other options, restricted units and performance share units are forfeited.

JM                   JG
Employee                L3Harris

STM/bs/22-001    Page 12 of 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]